More News

06 Jan 2017 Momenta and CSL Announce Collaboration and License Agreement to Develop Fc Multimer Programs, Including M230, a Selective Immunomodulator of Fc Receptors
06 Jan 2017 Ionis and Akcea Enter into Strategic Collaboration with Global Pharmaceutical Company to Develop and Commercialize AKCEA-APO(a)-L Rx and AKCEA-APOCIII-L Rx
05 Jan 2017 Avidity Biosciences Raises $16 Million in Series B Financing to Advance Antibody-siRNA Conjugate Platform
05 Jan 2017 TOT BIOPHARM and LEE'S PHARM Signed an Exclusive Licensing Agreement on Monoclonal Antibody Drug TAB014
05 Jan 2017 Biogen exercises option to enter into exclusive, worldwide License Agreement for Factor IX utilizing Amunix' XTEN(R) half-life extension technology
05 Jan 2017 Synthetic Genomics Announces Collaboration with Johnson & Johnson Innovation to Develop Novel Therapeutics Using Synthetic Genomics' Replicon RNA Technology
05 Jan 2017 CiVi Biopharma Receives Worldwide Exclusive License to Develop a Novel, RNA Targeted Drug Against PCSK-9
05 Jan 2017 Takeda and PvP Biologics Announce Development Agreement around Novel Therapeutic for Celiac Disease
05 Jan 2017 Pieris Pharmaceuticals and Servier Forge Strategic Immuno-oncology Co-development Alliance
05 Jan 2017 NeRRe Therapeutics Raises £23 Million in Oversubscribed Series B Financing Round
05 Jan 2017 Arena Pharmaceuticals and Eisai Amend Marketing and Supply Agreement for BELVIQ Globally
04 Jan 2017 Pionyr Immunotherapeutics Closes Financing with Focus on Developing Antibody-based Immuno-oncology Therapeutics
04 Jan 2017 NOXXON Pharma Licenses and Assigns Preclinical Spiegelmer Programs to Aptarion
04 Jan 2017 Affimed and MD Anderson Announce Clinical Immuno-Oncology Development Collaboration
04 Jan 2017 RaNA Acquires Shire’s Industry Leading Messenger RNA Platform
04 Jan 2017 MyoKardia Announces Advancement to Next Phase of Global Collaboration with Sanofi
04 Jan 2017 Sharp Edge Labs Enters into Drug Discovery Collaboration with Sumitomo Dainippon Pharma
04 Jan 2017 Kowa Pharmaceuticals America, Inc. Announces Agreement with CymaBay Therapeutics to License Gout Compound
04 Jan 2017 APT Therapeutics Inc. Enters Worldwide Collaboration, Option and Asset Purchase Agreement for Investigation of Human Apyrase Therapy
03 Jan 2017 Tiziana Life Sciences In-Licenses NI-1201, a Fully Human anti-IL-6R Monoclonal Antibody
28 Dec 2016 OSE Immunotherapeutics signs a license option agreement with Servier to develop and commercialize the product Effi-7
24 Dec 2016 Benitec in-licenses clinical program for head and neck cancer from NantWorks
23 Dec 2016 Genticel and Genkyotex Announce Intention to Enter into Strategic Combination
23 Dec 2016 Ligand Enters into Worldwide OmniAb® Platform License Agreement with ONO PHARMACEUTICAL CO., LTD.
22 Dec 2016 Medigene announces outlicensing of AAVLP technology

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top